The stock's rise snapped a three-day losing streak.

Dividend investing hardly loses its allure but gains more attention when the Fed cuts interest rates. A recent report from ...

As we move further into October, many investors may be looking to identify certain stocks with the potential to provide ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Two supercharged income stocks -- sporting yields of 5.6% and 5.8% -- have the tools and intangibles needed to catapult ...

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

The consensus among 31 analysts is a "Moderate Buy." The struggles of Intel, Boeing, and Nike in 2024 raises questions about their future in the Dow Jones index, as these stocks continue to lag ...

In a previous interview, Lee hinted that a period of market volatility is expected, as 2024 heads for a soft landing.

Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie ...

We recently compiled a list of the David Einhorn’s Stock Portfolio: Top 10 Stocks to Buy. In this article, we are going to ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...